• Identify and tackle important, unresolved issues in clinical biobanking that could benefit from broader discussion. 
• Develop communications such as journal publications,  communication/actions to funding agencies/governments, position papers,  letters, and presentations to clinical/scientific meetings that address issues relevant to clinical biobanks and provide strategies for addressing such items. 
• Provide ISBER clinical biobanking representation to ISBER external organizations as FIBO, OECD etc etc.
• Increase ISBER clinical biobank visibility as well as identification for ISBER clinical biobanking members.

Representation from the working group in external groups as FIBO, need to be discussed and given shape in ISBER council.